FDA reviews peptide injections favored by RFK Jr. and wellness influencers
- Posted on July 23, 2026
- By The Toronto Star
- 1 Views
- 1 min read
The FDA is conducting a comprehensive review of peptide-based supplements gaining popularity among wellness advocates and public figures like RFK Jr. These injectable compounds lack substantial clinical evidence regarding their safety and efficacy profiles. The regulatory assessment aims to evaluate multiple peptide formulations currently marketed to consumers seeking performance enhancement and longevity benefits, despite limited scientific validation supporting their health claims and long-term safety profiles.
Summary auto-generated by AI from the original publisher's content. Editorial standards.